Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daren Fearon

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Biorxiv : the Preprint Server for Biology|September 4, 2024
Identifying novel chemical matter against the Chikungunya virus nsP3 macrodomain through crystallographic fragment screeningJasmin C Aschenbrenner, Andre Schutzer de Godoy, Michael Fairhead, et al.
Science Advances|June 21, 2023
Accelerating drug target inhibitor discovery with a deep generative foundation modelVijil Chenthamarakshan, Samuel C Hoffman, C David Owen, et al.
Biorxiv : the Preprint Server for Biology|July 7, 2022
Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 Macrodomain of SARS-CoV-2Stefan Gahbauer, Galen J Correy, Marion Schuller, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Crystallographic Fragment Screen of Coxsackievirus A16 2A Protease identifies new opportunities for the development of broad-spectrum anti-enteroviralsRyan M Lithgo, Charles W E Tomlinson, Michael Fairhead, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2023
Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2Stefan Gahbauer, Galen J Correy, Marion Schuller, et al.
Chemmedchem|February 22, 2022
Expanding the Repertoire of Low-Molecular-Weight Pentafluorosulfanyl-Substituted ScaffoldsArathy Jose, Daniel Guest, Remi LeGay, et al.
Research Square|February 24, 2025
Crystallographic fragment screening and deep mutational scanning of Zika virus NS2B-NS3 protease enable development of resistance-resilient inhibitorsFrank von Delft, Xiaomin Ni, R Richardson, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
High-throughput crystallographic fragment screening of Zika virus NS3 HelicaseAndre S Godoy, Nathalya C M R Mesquita, Gabriela Dias Noske, et al.
Nucleic Acids Research|April 28, 2023
Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonucleaseAndre Schutzer Godoy, Aline Minalli Nakamura, Alice Douangamath, et al.
Nature Communications|November 25, 2024
Critical assessment of LC3/GABARAP ligands used for degrader development and ligandability of LC3/GABARAP binding pocketsMartin P Schwalm, Johannes Dopfer, Adarsh Kumar, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Biorxiv : the Preprint Server for Biology|September 4, 2024
Identifying novel chemical matter against the Chikungunya virus nsP3 macrodomain through crystallographic fragment screeningJasmin C Aschenbrenner, Andre Schutzer de Godoy, Michael Fairhead, et al.
Science Advances|June 21, 2023
Accelerating drug target inhibitor discovery with a deep generative foundation modelVijil Chenthamarakshan, Samuel C Hoffman, C David Owen, et al.
Biorxiv : the Preprint Server for Biology|July 7, 2022
Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 Macrodomain of SARS-CoV-2Stefan Gahbauer, Galen J Correy, Marion Schuller, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Crystallographic Fragment Screen of Coxsackievirus A16 2A Protease identifies new opportunities for the development of broad-spectrum anti-enteroviralsRyan M Lithgo, Charles W E Tomlinson, Michael Fairhead, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2023
Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2Stefan Gahbauer, Galen J Correy, Marion Schuller, et al.
Chemmedchem|February 22, 2022
Expanding the Repertoire of Low-Molecular-Weight Pentafluorosulfanyl-Substituted ScaffoldsArathy Jose, Daniel Guest, Remi LeGay, et al.
Research Square|February 24, 2025
Crystallographic fragment screening and deep mutational scanning of Zika virus NS2B-NS3 protease enable development of resistance-resilient inhibitorsFrank von Delft, Xiaomin Ni, R Richardson, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
High-throughput crystallographic fragment screening of Zika virus NS3 HelicaseAndre S Godoy, Nathalya C M R Mesquita, Gabriela Dias Noske, et al.
Nucleic Acids Research|April 28, 2023
Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonucleaseAndre Schutzer Godoy, Aline Minalli Nakamura, Alice Douangamath, et al.
Nature Communications|November 25, 2024
Critical assessment of LC3/GABARAP ligands used for degrader development and ligandability of LC3/GABARAP binding pocketsMartin P Schwalm, Johannes Dopfer, Adarsh Kumar, et al.
Pageof 5